Main navigation
- Home
- About us
- Medicines
- Research
- Careers
- Responsibility
- Strategy and vision
- Patient safety
- Human rights
- Access to medicines
- In the developing world
- Sales & marketing ethics
- Research ethics
- Animal research
- Clinical trials
- Our employees
- Community support
- Climate change
- Sustainable production
- Pharmaceuticals in the environment
- Working with suppliers
- Management & measurement
- Code, policies & standards
- Reporting performance
- Partnering
- Media
- Investors
You are here
- Home
- Responsibility
Working with suppliers
Our commitment to responsible business extends to ensuring that we work only with suppliers who embrace standards of ethical behaviour that are consistent with our own.
To further strengthen our ability to deliver our commitment, we developed the AstraZeneca Responsible Procurement Process, as described in our Global Responsible Procurement Standard, which we published in 2009. The Process centres on a risk-based approach to integrating our ethical standards into our procurement activity and decision-making and it applies across the full range of our procurement activity worldwide.
We continue to consolidate the number of suppliers we use across our business activities, implementing global, regional and local relationships with a smaller number of more strategic suppliers whilst continuing to maintain the right level of supplier diversity. This consolidation of our supply base is helping us to gain a better understanding of our suppliers and develop stronger, more sustainable relationships with them, including embedding our responsible procurement approach effectively.
Our Global Procurement function leads the development of procurement strategies and objectives. They work closely with our Global Corporate Responsibility team and Compliance networks across the organisation to provide the expert support and training necessary to ensure our requirements are understood and applied by all those involved in procurement on behalf of AstraZeneca.
-
The content of this page was externally assured by Bureau Veritas, February 2010.
Not signed in
Page tools
Share price
- London
-
28.96 GBP - New York
-
44.71 USD - Stockholm
-
313.80 SEK
At 18-Mar-2010 00:25 GMT
Detailed share price-
PDF basket collapse
Use your basket to collect pages in PDF format which can then be viewed as a single PDF.
On the issues
We communicate openly on key issues that affect or concern our stakeholders, including:
